Last 23 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.33 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 7.40 | 7.41 | 7.67 | 5.97 | 8.95 | 7.64 | 8.83 | 10.01 | 7.44 | 8.49 | 16.98 | 15.13 | 23.59 |
| — | -3.0% | -13.1% | -40.3% | +20.2% | -9.9% | -48.0% | -33.9% | -68.4% | -72.3% | -55.9% | -78.8% | -79.6% | |
| P/B Ratio | 0.35 | 0.45 | 0.43 | 0.32 | 0.43 | 0.35 | 0.30 | 0.32 | 0.31 | 0.35 | 0.65 | 0.57 | 0.81 |
| — | +28.6% | +44.9% | +0.9% | +37.6% | +0.4% | -54.3% | -43.5% | -61.5% | -67.1% | -44.9% | -70.8% | -70.8% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Seer, Inc.'s operating margin was -469.4% in Q3 2025, up 37.3 pp QoQ and up 147.6 pp YoY. The trailing four-quarter average of -516.3% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 9.2% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.0% | 51.2% | 52.1% | 49.0% | 9.3% | 46.9% | 7.5% | -4.3% | 41.7% | 15.8% | 23.0% | 18.8% | 40.2% |
| — | +9.2% | +599.1% | +1229.9% | -77.8% | +196.5% | -67.6% | -123.1% | +3.8% | -29.1% | +17.8% | +68.7% | +375.6% | |
| Operating Margin | -717.7% | -469.4% | -506.8% | -493.0% | -596.1% | -617.1% | -882.0% | -821.7% | -531.9% | -621.0% | -697.1% | -677.2% | -646.2% |
| — | +23.9% | +42.5% | +40.0% | -12.1% | +0.6% | -26.5% | -21.3% | +17.7% | +2.0% | -7.7% | +5.7% | +1.6% | |
| Net Margin | -620.9% | -442.5% | -479.5% | -474.4% | -550.6% | -541.0% | -743.8% | -674.5% | -425.8% | -506.7% | -584.6% | -591.1% | -583.4% |
| — | +18.2% | +35.5% | +29.7% | -29.3% | -6.8% | -27.2% | -14.1% | +27.0% | +16.4% | +7.2% | +17.2% | +10.4% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -23.9% | -6.5% | -6.5% | -6.2% | -6.5% | -6.0% | -6.1% | -5.3% | -4.4% | -5.1% | -5.5% | -5.4% | -5.0% |
| — | -8.3% | -6.1% | -17.9% | -45.8% | -17.4% | -10.9% | +2.7% | +10.9% | +0.7% | -15.7% | -13.9% | -28.4% | |
| ROA | -21.6% | -5.8% | -5.8% | -5.6% | -5.8% | -5.4% | -5.5% | -4.8% | -4.0% | -4.7% | -5.0% | -5.0% | -4.6% |
| — | -7.0% | -5.2% | -16.0% | -43.5% | -16.0% | -9.9% | +3.4% | +11.4% | +1.3% | -14.7% | -12.4% | -23.2% | |
| ROIC | -21.3% | -5.5% | -5.5% | -5.2% | -5.5% | -5.3% | -5.7% | -5.0% | -4.2% | -4.9% | -5.2% | -4.9% | -4.4% |
| — | -4.8% | +2.9% | -3.4% | -29.5% | -7.1% | -9.0% | -2.6% | +5.0% | -10.1% | -5.7% | +19.5% | +29.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 22.4% YoY to 14.25x, tightening the short-term liquidity position. Debt/Equity has risen for 7 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| — | +16.1% | +15.9% | +13.2% | +11.3% | +8.2% | +5.9% | +4.6% | +6.5% | +9.0% | +10.3% | +11.0% | +44.1% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 16.53 | 14.25 | 19.15 | 19.34 | 16.53 | 18.36 | 17.59 | 25.27 | 25.00 | 27.65 | 21.22 | 31.26 | 34.57 |
| — | -22.4% | +8.8% | -23.4% | -33.9% | -33.6% | -17.1% | -19.2% | -27.7% | -16.4% | -31.7% | -23.8% | +12.7% | |
| Quick Ratio | 16.04 | 13.71 | 18.51 | 18.81 | 16.04 | 17.88 | 17.15 | 24.81 | 24.66 | 27.31 | 20.89 | 30.94 | 34.20 |
| — | -23.3% | +8.0% | -24.2% | -34.9% | -34.5% | -17.9% | -19.8% | -27.9% | -16.3% | -31.8% | -24.0% | +12.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonSeer, Inc.'s current P/E is -1.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Seer, Inc.'s current operating margin is -717.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Seer, Inc.'s business trajectory between earnings reports.